Featured

Mar 17, 2025

An important update regarding registration and supply of Prochlorperazine - Prochlorperazine 3mg buccal tablets are now registered and listed on the schedule*

Mar 17, 2025

Read More →

Mar 17, 2025

Feb 1, 2025

NEW Product Launch - Stalevo® Tablets from Orion Pharma and Max Health

Feb 1, 2025

Read More →

Feb 1, 2025

Nov 25, 2024

NEW Product Launch Modafinil 100mg Tablets from Max Health

Nov 25, 2024

Read More →

Nov 25, 2024

Aug 29, 2024

Levocarnitine 500mg capsules- Schedule Listed from 1st September

Aug 29, 2024

Read More →

Aug 29, 2024

Aug 26, 2024

Modafinil Tablets – New Tender Listing – Section B and Section H

Aug 26, 2024

Read More →

Aug 26, 2024

Aug 15, 2024

Max Health Innovation Grant 2024 - ENTRIES OPEN

Aug 15, 2024

Read More →

Aug 15, 2024

Nov 15, 2023

Nicorandil Tablets – New Tender Listing – Section B and Section H

Nov 15, 2023

Read More →

Nov 15, 2023

May 10, 2023

Max Health Pharmacy Innovation Showcase Award 2023

May 10, 2023

Read More →

May 10, 2023

Feb 13, 2023

New Max Health team members - welcoming Lisa Chang and Leanne Carpendale

Feb 13, 2023

Read More →

Feb 13, 2023

Dec 5, 2022

Clinical pharmacist, Fiona McNabb wins Max Health Pharmacy Innovation Showcase Award 2022

Dec 5, 2022

Read More →

Dec 5, 2022

Oct 20, 2022

Levomepromazine Injection – New Tender Listing – Section B and Section H

Oct 20, 2022

Read More →

Oct 20, 2022

Oct 14, 2022

Max Health and Hameln to launch Clindamycin 150mg/mL solution for injection into the New Zealand pharmaceutical market.

Oct 14, 2022

Read More →

Oct 14, 2022

Jul 6, 2022

New Schedule Listings - Alliance Pharmaceuticals

Jul 6, 2022

Read More →

Jul 6, 2022

Apr 4, 2022

New Tender Listing – An Addition to Hameln’s Portfolio

Apr 4, 2022

Read More →

Apr 4, 2022

Mar 28, 2022

Partner Update – A Focus on Hameln

Mar 28, 2022

Read More →

Mar 28, 2022